Advantage Alpha Capital Partners LP Has $491,000 Stake in MiMedx Group, Inc. (NASDAQ:MDXG)

Advantage Alpha Capital Partners LP reduced its position in shares of MiMedx Group, Inc. (NASDAQ:MDXG) by 34.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 82,883 shares of the company’s stock after selling 43,709 shares during the quarter. Advantage Alpha Capital Partners LP owned 0.06% of MiMedx Group worth $491,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the business. ProShare Advisors LLC raised its position in MiMedx Group by 8.5% during the first quarter. ProShare Advisors LLC now owns 20,735 shares of the company’s stock valued at $160,000 after buying an additional 1,631 shares during the period. Allspring Global Investments Holdings LLC increased its holdings in shares of MiMedx Group by 1.0% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 183,021 shares of the company’s stock valued at $1,082,000 after purchasing an additional 1,822 shares during the period. Hsbc Holdings PLC increased its holdings in shares of MiMedx Group by 7.3% in the 2nd quarter. Hsbc Holdings PLC now owns 34,343 shares of the company’s stock valued at $233,000 after purchasing an additional 2,329 shares during the period. The Manufacturers Life Insurance Company lifted its position in shares of MiMedx Group by 7.6% in the second quarter. The Manufacturers Life Insurance Company now owns 45,623 shares of the company’s stock worth $316,000 after purchasing an additional 3,222 shares in the last quarter. Finally, Marshall Wace LLP boosted its holdings in shares of MiMedx Group by 1.1% during the second quarter. Marshall Wace LLP now owns 298,818 shares of the company’s stock worth $2,071,000 after purchasing an additional 3,223 shares during the period. Hedge funds and other institutional investors own 79.15% of the company’s stock.

MiMedx Group Trading Up 1.5 %

Shares of NASDAQ:MDXG opened at $9.23 on Wednesday. The company has a current ratio of 4.10, a quick ratio of 3.53 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $1.36 billion, a PE ratio of 16.78 and a beta of 1.94. MiMedx Group, Inc. has a 1 year low of $5.47 and a 1 year high of $9.49. The firm has a fifty day moving average price of $6.72 and a 200 day moving average price of $6.86.

Analyst Ratings Changes

A number of research firms have issued reports on MDXG. StockNews.com downgraded shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a research report on Friday, November 8th. Cantor Fitzgerald reissued an “overweight” rating and set a $11.00 price objective on shares of MiMedx Group in a research report on Thursday, August 1st. Finally, Craig Hallum dropped their target price on MiMedx Group from $14.00 to $12.00 and set a “buy” rating on the stock in a research report on Thursday, August 1st. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $12.00.

About MiMedx Group

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.